RPCA
SRNE

Running Point Capital Advisors’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Running Point Capital Advisors’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-10,000
Closed -$16K – 237
2022
Q3 		$16K Hold
10,000
– – 0.01% 189
2022
Q2 		$20K Hold
10,000
– – 0.01% 185
2022
Q1 		$23K Buy
+10,000
New +$23K 0.01% 180